Hartwin Pharmaceuticals Private Limited
About Hartwin Pharmaceuticals Private Limited
Data last updated:
Hartwin Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2016PTC087943. Its GSTIN is 09AAECH0190D1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹9 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gunjan Tyagi and Shreya Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P – 1/A – 205 Ashiyana Palmcourt Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201003.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.78 Lakh, a decline of 28% compared to the previous year. For the same year it recorded a net loss of ₹54,991 (net margin -31%) and EBITDA of -₹50,635 (EBITDA margin -28.5%). Revenue has declined at a compounded annual rate (CAGR) of 53% over three years and 37% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressP – 1/A – 205 Ashiyana Palmcourt Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201003
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hartwin Pharmaceuticals Private Limited
The main business activity of Hartwin Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hartwin Pharmaceuticals Private Limited FY 2025 filings available
Hartwin Pharmaceuticals Private Limited reported revenue of ₹1.78 Lakh (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Hartwin Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 37% over five years, including a 28% fall in the latest year. EBITDA fell 707% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Hartwin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹50,635 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹54,991 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hartwin Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -28.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -31% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hartwin Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Hartwin Pharmaceuticals Private Limited
Hartwin Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Epione Med RX Pharmacy Private Limited | ₹1.79 Lakh (FY 2023) | •••• | •••• | -99.0% | •••• | Jaipur, Rajasthan, India |
| Veervill Private Limited | ₹1.79 Lakh (FY 2025) | •••• | •••• | -46.0% | •••• | Thanjavur, Tamil Nadu, India |
| Steadmed Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2024) | •••• | •••• | 153.0% | •••• | Kanpur, Uttar Pradesh, India |
| Strikar Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2019) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Sirois Pharmaceuticals Private Limited | ₹1.78 Lakh (FY 2024) | •••• | •••• | 2540843.0% | •••• | Dehradun, Uttarakhand, India |
| Hartwin Pharmaceuticals Private Limited this company | ₹1.78 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Airiza Pharmaceuticals Private Limited | ₹1.77 Lakh (FY 2022) | •••• | •••• | -17.0% | •••• | Asansol, West Bengal, India |
| Goldman Pharmaceuticals Private Limited | ₹1.77 Lakh (FY 2025) | •••• | •••• | •••• | Ghaziabad, Uttar Pradesh, India | |
| Echomet Pharmaceuticals Private Limited | ₹1.77 Lakh (FY 2025) | •••• | •••• | •••• | Ranchi, Jharkhand, India | |
| Proxima Pharmaceuticals Marketing Private Limited | ₹1.76 Lakh (FY 2020) | •••• | •••• | 11.0% | •••• | Bhopal, Madhya Pradesh, India |
| Brinj Pharmaceuticals Private Limited | ₹1.76 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Shivpuri, Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Hartwin Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Hartwin Pharmaceuticals Private Limited
Hartwin Pharmaceuticals Private Limited is audited by Vaa & Associates for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Vaa & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Hartwin Pharmaceuticals Private Limited
Hartwin Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gunjan Tyagi | Director | 24 Nov 2016 | 9 Years 10 Months | Current |
| Shreya Tyagi | Director | 15 Jun 2023 | 3 Years 3 Months | Current |
| Veerendra Singh | Director | 28 Oct 2025 | 0 Years 11 Months | Current |
Ownership and Shareholding of Hartwin Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hartwin Pharmaceuticals Private Limited
Hartwin Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Hartwin Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Hartwin Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hartwin Pharmaceuticals Private Limited
Hartwin Pharmaceuticals Private Limited has 5 board changes on record since 2016: 3 appointments and 2 cessations. The latest: Veerendra Singh was appointed as Director on 28 Oct 2025.
Credit Ratings, Litigation & Regulatory Alerts for Hartwin Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hartwin Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hartwin Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hartwin Pharmaceuticals Private Limited
Hartwin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECH0190D1ZW | Uttar Pradesh | Active | 06 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hartwin Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hartwin Pharmaceuticals Private Limited
Hartwin Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 November 2016 (10+ years old) and is registered under CIN U74999UP2016PTC087943.
Hartwin Pharmaceuticals reported revenue of ₹1.78 Lakh for FY 2025 (down 28% YoY).
Hartwin Pharmaceuticals has 3 current directors:
- Gunjan Tyagi - Director
- Shreya Tyagi - Director
- Veerendra Singh - Director
Hartwin Pharmaceuticals reported a net loss of ₹54,991 (net margin -31%) and EBITDA of -₹50,635 (EBITDA margin -28.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Hartwin Pharmaceuticals is -53% over three years and -37% over five years. In the latest year (FY 2025) revenue fell 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Hartwin Pharmaceuticals is 09AAECH0190D1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Hartwin Pharmaceuticals is U74999UP2016PTC087943. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hartwin Pharmaceuticals was incorporated on 24 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Hartwin Pharmaceuticals by revenue are Epione Med RX Pharmacy Private Limited, Veervill Private Limited, Steadmed Pharmaceuticals Private Limited, Strikar Pharmaceuticals Private Limited, Sirois Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Veerendra Singh was appointed as Director on 28 Oct 2025. Rishi Kant ceased to be Director on 02 Nov 2023. Shreya Tyagi was appointed as Director on 15 Jun 2023. Hartwin Pharmaceuticals has 5 board changes on record in total.
The registered office of Hartwin Pharmaceuticals is at P – 1A – 205 Ashiyana Palmcourt Raj Nagar Extension, Ghaziabad, Uttar Pradesh, India – 201003.